期刊文献+

N-苯甲酰基金刚烷甲酰肼类化合物的合成 被引量:1

The synthesis of N-benzoyl-adamantane formyl hydrazines
下载PDF
导出
摘要 以金刚烷甲酸、甲醇为原料,浓硫酸为催化剂,经酯化反应合成金刚烷甲酸甲酯,再以金刚烷甲酸甲酯为原料,加入水合肼,经酰化反应合成金刚烷甲酰肼。将金刚烷甲酰肼与不同的芳香酰氯反应,合成五个N-芳甲酰基-金刚烷甲酰肼化合物。目标化合物结构经ESI-MS谱图确证。 Adamantane formic acid and methanol as raw materials, concentrated sulfuric acid as catalyst, the esterifieation reaction of synthesis of adamantane methyl formate. Again with adamantane methyl formate as raw material, adding hydrazine hydrate, through aeylation reaction synthesis of adamantane formyl hydrazine. The adamantane formyl hydrazine reacted with different aromatic acid chloride, five design and synthesis of N - (instead of aromatic formyl) - adamantane formyl hydrazine compounds. The structure of target compounds were determined by HNMR and ESI - MS . The compounds are not seen to be reported in literatures.
出处 《北方药学》 2016年第5期123-124,共2页 Journal of North Pharmacy
基金 辽宁省大学生创新创业训练计划(20150956)
关键词 金刚烷甲酸 金刚烷甲酰肼 合成 Adamantane formic acid Adamantane formyl hydrazine Synthesis
  • 相关文献

参考文献8

  • 1Schnell J R, Chou J J. Structure and mechanism of the M2 pro- ton channel of influenza A virus [J]. Nature, 2008,451 : 591-595.
  • 2Webster R G., Virology A molecular whodunit [J]. Science, 2001,293 (5536) : 1773-1775.
  • 3殷璐,蒋建东.抗流感病毒药物研究进展[J].中国新药杂志,2004,13(8):685-687. 被引量:22
  • 4张强,赵庆杰,熊瑞生,李剑峰,沈敬山.抗流感病毒药物研究进展[J].药学学报,2010,45(3):289-299. 被引量:32
  • 5SAITO R, LID J, SUZUKI H. Amantadine-resistant influenza A(H3N2)virus, Japan, in 2005-2006 season [J]. N Engl J Med, 2007,356(3 ) : 312-313.
  • 6Andronova V L. Comparative study of the mechanism of inhibi- tion of Sindbis virus reproduction by adamantane derivatives:re- mantadine and amide of 1-adamantane earboxylie acid [J]. An- tibiot Khimioter, 1996,41 (7/8) : 26-30.
  • 7Ghada S. Hassan, All A. E1-Emam, Laila M. Gad, Alaa Eldin M. Barghash .Synthesis, antimierobial and antiviral testing of some new 1-adamantyl analogues[J]. Saudi Pharmaceutical Journal,2010 (18) : 123-128.
  • 8李德江,葛正红.2-苯基-5-芳基-1,3,4-噁二唑的合成与表征[J].合成化学,2004,12(6):532-535. 被引量:12

二级参考文献18

  • 1王孟昭,蔡柏蔷,李龙芸,林江涛,苏楠,俞红霞,高和,赵建忠,刘丽.阿比朵尔治疗流行性感冒的随机、双盲、安慰剂对照、多中心临床研究[J].中国医学科学院学报,2004,26(3):289-293. 被引量:38
  • 2杨骏,花文廷.2,5-二取代-1,3,4-噁二唑类化合物的合成[J].化学通报,1996(9):18-26. 被引量:39
  • 3石钺,石任兵.银翘散抗流感病毒有效部位各组分变化及归属分析[J].药学学报,2007,42(2):192-196. 被引量:21
  • 4[2]Wutzler P,Volge PG.Neuraminidase inhibitors in the treatment of influenza A and B--Overview and case report[J].Infection,2000,28(5):261-266.
  • 5[3]Stiver G.The treatment of influenza with antiviral drugs[J].CMAJ,2003,168(1):49-56.
  • 6[4]Laver WG,Bischofberger N,Webster RG.Disarming flu viruses[J].Sci Am,1999,280(1):78-87.
  • 7[5]McNicholl IR,McNicholl JJ.Neuraminidase inhibitors:zanamivir and oseltamivir[J].Ann Pharmacother,2001,35(1):57-70.
  • 8[6]Freund B,Gravenstein S,Elliott M,et al.Zanamivir:a review of clinical safety[J].Drug Safe,1999,21(4):267-281.
  • 9[7]Lalezari J,Campion K,Keene O,et al.Zanamivir for the treatment of influenza A and B infection in high-risk patients:a pooled analysis of randomized controlled trials[J].Arch Intern Med,2001,161(2):212-217.
  • 10[8]Diggory P,Fernandez C,Humphrey A,et al.Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir:randomized controlled trial[J].BMJ,2001,322(7286):577-579.

共引文献55

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部